NCT02252601 Evaluation of the High Frequency Digit Triplet Test in Cystic Fibrosis Status UNKNOWN Phase NA
NCT02239458 DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis Status UNKNOWN Phase NA
NCT02212587 Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex Status COMPLETED Phase PHASE1
NCT02202876 Redox Imbalance and the Development of Cystic Fibrosis Diabetes Status COMPLETED Phase NA
NCT02201082 Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session Status COMPLETED Phase NA
NCT02199340 The iStep Study: Development and Validation of an Incremental Exercise Step Test for Children With Cystic Fibrosis Status COMPLETED Phase NA
NCT02198079 A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida Status COMPLETED Phase N/A
NCT02194881 Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation Status COMPLETED Phase N/A
NCT02190604 Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients Status TERMINATED Phase PHASE1/PHASE2
NCT02188758 Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment Status COMPLETED Phase N/A
NCT02179710 Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study Status COMPLETED Phase N/A
NCT02178540 Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients Status COMPLETED Phase PHASE4
NCT02172534 Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients Status COMPLETED Phase PHASE1